Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
134
days
Highly Efficient Derivation of Functional Human-Induced Pluripotent Stem Cell-Derived Macrophages under Serum-Free Conditions to Study Innate Immune Responses
Authors
Hani Hosseini Far; Le Ying; Linden J. Gearing; Rachelia R. Wibawa; Trevor J. Wilson; Ali Motezadian; Michelle D. Tate; Elizabeth L. Hartland; Christine A. Wells; Paul J. HertzogShow moreShow less
Affiliations
1. Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia; 2. Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia; 3. MHTP Medical Genomics Facility, Hudson Institute of Medical Research, Clayton, VIC, Australia; 4. Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; 5. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia; 6. Stem Cell Systems, Department of Anatomy and Physiology, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC, AustraliaShow moreShow less
246
days
Differential Effects of Zanubrutinib and Ibrutinib on Neutrophil Antifungal Functions: Insights from Live-Cell Imaging
Authors
Benoit S. Marteyn; Aymeric Silvin; Tamou Thahouly; Nathan Broussaudier; Jean-Daniel Fauny; Marina Valente Barroso; Thierry Fontaine; Kamel Laribi; David GhezShow moreShow less
Affiliations
1. Université de Strasbourg, Institut de Biologie Moléculaire et Cellulaire (IBMC), CNRS UPR9002, Strasbourg, France; 2. Institut Pasteur, INSERM U1225, Unité de Pathogenèse des Infections Vasculaires, Paris, France; 3. University of Strasbourg Institute for Advanced Study (USIAS), Paris, France; 4. INSERM U1015, Institut Gustave Roussy, Villejuif, France; 5. Université de Strasbourg, Institut de Biologie Moléculaire et Cellulaire (IBMC), CNRS UPR3572 Strasbourg, France; 6. Institut Pasteur, Unité Biologie et Pathogénicité Fongiques, Paris Cedex 15, France; 7. Centre Hospitalier Le Mans, Service Hématologie Clinique, Le Mans, France; 8. Institut Gustave Roussy, Département d’Hématologie, Villejuif, France; 9. Inserm UMR, Institut Gustave Roussy, Villejuif, FranceShow moreShow less
167
days
The Small Ubiquitin-Like Modifier SUMO-3 Acts as a Neutrophil Chemoattractant via the Chemokine Receptors CXCR1 and CXCR2
Authors
Sean P. Giblin; Vlad Razvan Moiseanu; Christina Josephine Carrington; Audrey Naing; Killian Watkins; Tomoko Tsuchiya; Shiro Kanegasaki; James Edward PeaseShow moreShow less
Affiliations
1. Inflammation, Repair and Development Section, National Heart and Lung Institute, Imperial College London, London, UK; 2. Research Institute, National Center for Global Health and Medicine, Tokyo, Japan; 3. Gunma University, Heavy Ion Medical Center, Maebashi City, JapanShow moreShow less
133
days
Association of CD32-131H>R Polymorphism with End-Stage Chronic Obstructive Pulmonary Disease and Interstitial Lung Diseases
Authors
Sarah M. Berger; Laura M. Kühner; Ines M. Schwarzinger; Verena Heiss Spornberger; Peter Jaksch; Elisabeth Puchhammer-Stöckl; Hannes VietzenShow moreShow less
Affiliations
1. Center for Virology, Medical University of Vienna, Vienna, Austria; 2. Department of Internal Medicine, Franziskus Spital Margareten, Vienna, Austria; 3. Division of Thoracic Surgery, Medical University of Vienna, Vienna, AustriaShow moreShow less
84
days
Smad2/3 Regulates IL-6R m6A Methylation through METTL3 to Influence Inflammatory Responses in Hemorrhoidal Disease
Authors
Chunling Li; Xu Han; Aili Chen; Jian Cheng; Yalong Li; Qiong Wang; Heng ZhangShow moreShow less
Affiliations
1. Department of Hemorrhoid Fistula, Kunming Municipal Hospital of Traditional Chinese Medicine, Kunming, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days